As a remark, while the current study provides a first qualitative indication that Nb15 can be used to target myeloid cells in a glioma model, proof that the method can also be used in a quantitative manner to track accumulation of SIPRα-expressing myeloid cells or to monitor upregulation of SIRPα expression has not been provided. This evidence concerns the gene SIRPA and central nervous system cancer.